mHealth for Opioid and Stimulant Recovery in Black/African American Adults
This study is looking at how a mobile health (mHealth) program called uMAT-R can help Black and African American adults who are recovering from opioid or stimulant use. Researchers want to see if adding extra community engagement (in-person interactions) to the uMAT-R program, called uMAT-R + enhanced community engagement, works better than the original uMAT-R program alone. The goal is to improve recovery and mental health, including symptoms of depression and anxiety. To join, you must be 18 or older, identify as Black or African American, have a history of opioid and/or stimulant use, and be seeking treatment at local centers. The study will measure changes in substance use and symptoms of opioid/stimulant use disorder after one month to see if the interventions are successful. The study aims to enroll 300 participants.
- Study design
- This interventional study compares two versions of a mobile health program (uMAT-R and uMAT-R + enhanced community engagement) in 300 participants. It is a sequential trial, meaning the interventions are compared in a specific order.
- What's involved
- Participants will engage with the uMAT-R mobile health intervention, potentially with enhanced community engagement. Substance use and disorder symptoms will be measured at the start and after one month.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one month after starting the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
At a glance
Conditions
NCT07673380
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Washington University School of Medicine
St Louis, Missouristudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Abstinence/ Changes in Substance UseTime 0 (Baseline) and Time 1 (One Month)
Frequency of opioid use, stimulant, and/or other substance use (e.g., discordant with prescribed usage) or other substances (e.g., stimulants, other non-opioid illicit drugs) in the past 30-day will be assessed by items from the National Survey on Drug Use and Health (NSDUH) questionnaire. The score indicates days on using any substance listed above over past 30-day, ranging from 0 to 30, with a higher score reflecting more frequent substance use.
- Opioid use/ Stimulant use disorder symptomsTime 0 (Baseline) and Time 1 (One Month)
The number of DSM-5-TR diagnostic criteria met for opioid use disorder (OUD) and stimulant use disorder (StUD) will be assessed. Scores range from 0 to 11, with higher scores indicating that more diagnostic criteria are met for the disorder.